Jennifer H. Lin, PhD

Senior Director
Pacira BioSciences, Inc.

Poster(s):

• (1) Intraoperative liposomal bupivacaine is associated with improved pain, opioid use, functional, and length of stay outcomes after total knee arthroplasty: real-world evidence
  Wednesday, October 29, 2025

• (3) Clinical and health economic outcomes with and without liposomal bupivacaine in Medicare-insured patients undergoing outpatient shoulder arthroplasty
  Wednesday, October 29, 2025

• (4) Impact of liposomal bupivacaine on healthcare resource utilization and costs in patients undergoing total knee arthroplasty in real-world ambulatory surgical centers
  Wednesday, October 29, 2025